Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Cortellini

Showing results (21-30 of 257) with videos related to

Pageof 26
Sort By:
Clinical Lung Cancer|September 23, 2023
Impact of Neoadjuvant Immune Checkpoint Inhibitors on Surgery and Perioperative Complications in Patients With Non-small-cell Lung Cancer: A Systematic ReviewKazuki Takada, Shinkichi Takamori, Leonardo Brunetti, et al.
Case Reports in Oncological Medicine|March 19, 2019
Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on DialysisAlessandro Parisi, Alessio Cortellini, Katia Cannita, et al.
Journal of Global Oncology|July 9, 2019
Cancer Care After Natural Disaster: Different Countries, Similar ProblemsLucilla Verna, Alessio Cortellini, Raffaele Giusti, et al.
International Journal of Cancer|November 6, 2024
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trialKazuki Takada, Shinkichi Takamori, Mototsugu Shimokawa, et al.
European Journal of Cancer Care|March 22, 2021
Into the storms: Organising oncological home care services during natural disasters and global pandemicsGiampiero Porzio, Lucilla Verna, Giulio Ravoni, et al.
International Journal of Molecular Sciences|January 20, 2018
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal CancerAdriano Angelucci, Simona Delle Monache, Alessio Cortellini, et al.
Lung Cancer Management|April 30, 2020
Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancerAlain Gelibter, Mario Occhipinti, Simona Pisegna, et al.
Thoracic Cancer|May 15, 2026
Impact of Anti-Inflammatory Drug Therapy on the Efficacy of First-Line Atezolizumab Treatment in Patients With Advanced Non-Small Cell Lung Cancer: An Integrated Analysis of Five Randomized Controlled TrialsKazuki Takada, Alessio Cortellini, Shinkichi Takamori, et al.
Lung Cancer (Amsterdam, Netherlands)|October 17, 2025
Probiotic supplement exposure and outcomes of patients with non-small cell lung cancer treated with first-line atezolizumab therapy: Pooled analysis of individual patient data from five randomized control trialsKazuki Takada, Mototsugu Shimokawa, Alessio Cortellini, et al.
Recenti Progressi in Medicina|April 23, 2020
[The CoViD-19 epidemic is posing entirely new problems for home cancer care services.]Giampiero Porzio, Flaminia Peris, Giulio Ravoni, et al.
Pageof 26

Showing results (21-30 of 257) with videos related to

Sort By:
Pageof 26
Clinical Lung Cancer|September 23, 2023
Impact of Neoadjuvant Immune Checkpoint Inhibitors on Surgery and Perioperative Complications in Patients With Non-small-cell Lung Cancer: A Systematic ReviewKazuki Takada, Shinkichi Takamori, Leonardo Brunetti, et al.
Case Reports in Oncological Medicine|March 19, 2019
Safe Administration of anti-PD-L1 Atezolizumab in a Patient with Metastatic Urothelial Cell Carcinoma and End-Stage Renal Disease on DialysisAlessandro Parisi, Alessio Cortellini, Katia Cannita, et al.
Journal of Global Oncology|July 9, 2019
Cancer Care After Natural Disaster: Different Countries, Similar ProblemsLucilla Verna, Alessio Cortellini, Raffaele Giusti, et al.
International Journal of Cancer|November 6, 2024
Prior antibiotics, proton pump inhibitors, and probiotics in patients with extensive stage small cell lung cancer treated with immune checkpoint blockade: A post-hoc analysis of the phase I/III IMpower 133 trialKazuki Takada, Shinkichi Takamori, Mototsugu Shimokawa, et al.
European Journal of Cancer Care|March 22, 2021
Into the storms: Organising oncological home care services during natural disasters and global pandemicsGiampiero Porzio, Lucilla Verna, Giulio Ravoni, et al.
International Journal of Molecular Sciences|January 20, 2018
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal CancerAdriano Angelucci, Simona Delle Monache, Alessio Cortellini, et al.
Lung Cancer Management|April 30, 2020
Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancerAlain Gelibter, Mario Occhipinti, Simona Pisegna, et al.
Thoracic Cancer|May 15, 2026
Impact of Anti-Inflammatory Drug Therapy on the Efficacy of First-Line Atezolizumab Treatment in Patients With Advanced Non-Small Cell Lung Cancer: An Integrated Analysis of Five Randomized Controlled TrialsKazuki Takada, Alessio Cortellini, Shinkichi Takamori, et al.
Lung Cancer (Amsterdam, Netherlands)|October 17, 2025
Probiotic supplement exposure and outcomes of patients with non-small cell lung cancer treated with first-line atezolizumab therapy: Pooled analysis of individual patient data from five randomized control trialsKazuki Takada, Mototsugu Shimokawa, Alessio Cortellini, et al.
Recenti Progressi in Medicina|April 23, 2020
[The CoViD-19 epidemic is posing entirely new problems for home cancer care services.]Giampiero Porzio, Flaminia Peris, Giulio Ravoni, et al.
Pageof 26